FDA approves leukemia drug from Roche

First Page		Document Content
Date: 2015-02-08 09:55:34 Cancer treatments Leukemia Orphan drugs B-cell chronic lymphocytic leukemia Chemotherapy Genentech Bevacizumab Acute myeloid leukemia Medicine Oncology Lymphocytic leukemia		FDA approves leukemia drug from Roche Add to Reading List Source URL: medicalxpress.com Download Document from Source Website File Size: 13,38 KB Share Document on Facebook

	MDACC LEUKEMIA AND LYMPHOMA Europe and the USA Linking Knowledge and Practice DocID: 1vhjk - View Document
	Genome-wide mapping of proviral integration sites in aggresive virus-induced leukemia Nicolas Rosewick1,2, Vincent Hahaut1, Maria Artesi1, Keith Durkin1, Ambroise Marçais3, Philip Griebel4, Natasa Arsic4, Véronique Ave DocID: 1vcJH - View Document
	Boswellic acid acetate induces apoptosis through caspase-mediated pathways in myeloid leukemia cells Lijuan Xia, Duo Chen, Rui Han, et al. Mol Cancer Ther 2005;4:Updated version DocID: 1v6bB - View Document
	The Dual E-selectin/CXCR4 Antagonist GMI-1359 Exerts Anti-leukemia Efficacy Against FLT3-ITDmutated Acute Myeloid Leukemia in A Patient-derived Xenograft Murine Model Mouse-1 Mouse-2 DocID: 1uSbg - View Document
	A Phase I/II Study of GMI-1271, a Novel E-selectin Antagonist, in Combination with Induction Chemotherapy in Relapsed/Refractory and Previously Untreated Elderly Patients with Acute Myeloid Leukemia; Results to Date Dan DocID: 1uJQ2 - View Document